Literature DB >> 24900083

Peripheral Tuberculous Lymphadenitis Masquerading as Metastatic Gastric Carcinoma on F-18 FDG Dual Time Point PET/CT.

Su Kon Kim1, Jeong Eun Shin2, Jai Hyuen Lee3.   

Abstract

Entities:  

Year:  2012        PMID： 24900083      PMCID： PMC4043069          DOI： 10.1007/s13139-012-0169-1

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  9 in total

1.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.

Authors:  R Hustinx; R J Smith; F Benard; D I Rosenthal; M Machtay; L A Farber; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-10

Review 2.  Current diagnosis and management of peripheral tuberculous lymphadenitis.

Authors:  Jose-Mario Fontanilla; Arti Barnes; C Fordham von Reyn
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

3.  Prognostic implication of dual-phase PET in adenocarcinoma of the lung.

Authors:  Mohamed Houseni; Wichana Chamroonrat; Jiyuan Zhuang; Rohit Gopal; Abass Alavi; Hongming Zhuang
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

4.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

Authors:  H Zhuang; M Pourdehnad; E S Lambright; A J Yamamoto; M Lanuti; P Li; P D Mozley; M D Rossman; S M Albelda; A Alavi
Journal:  J Nucl Med       Date:  2001-09       Impact factor: 10.057

5.  Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome.

Authors:  Andrea Polesky; William Grove; Gulshan Bhatia
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

Review 6.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors:  G J Cook; I Fogelman; M N Maisey
Journal:  Semin Nucl Med       Date:  1996-10       Impact factor: 4.446

7.  F-18-FDG uptake in tuberculosis.

Authors:  S M Bakheet; J Powe; A Ezzat; A Rostom
Journal:  Clin Nucl Med       Date:  1998-11       Impact factor: 7.794

8.  Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.

Authors:  Ur Metser; Einat Even-Sapir
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

9.  Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.

Authors:  Dae-Weung Kim; Soon-Ah Park; Chang Guhn Kim
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153
  9 in total
  2 in total

1.  Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.

Authors:  Hendra Budiawan; Gi Jeong Cheon; Hyung-Jun Im; Soo Jin Lee; Jin Chul Paeng; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-21

2.  Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.

Authors:  Hussein Farghaly; Mohamed Alshareef; Abdullah Alqarni; Mohamed Sayed; Hatem Nasr
Journal:  Eur J Radiol Open       Date:  2020-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.